Additionally, TLR4 and LY96, which are genes in the TLR signaling pathway that promote cell survival and proliferation in hepatocellular carcinoma (63, 64), were significantly downregulated in shTREM1 HepG2 tumors (Figure 8, G and H). This evidence concerns the gene TLR4 and hepatocellular carcinoma.